These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 31015004)

  • 41. Quantum Dots and their Potential Role in Cancer Theranostics.
    Tripathi SK; Kaur G; Khurana RK; Kapoor S; Singh B
    Crit Rev Ther Drug Carrier Syst; 2015; 32(6):461-502. PubMed ID: 26559550
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Graphene-like Metal-Free 2D Nanosheets for Cancer Imaging and Theranostics.
    Luo Y; Li Z; Zhu C; Cai X; Qu L; Du D; Lin Y
    Trends Biotechnol; 2018 Nov; 36(11):1145-1156. PubMed ID: 29954613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nanobiotechnology of Carbon Dots: A Review.
    Durán N; Simões MB; de Moraes ACM; Fávaro WJ; Seabra AB
    J Biomed Nanotechnol; 2016 Jul; 12(7):1323-47. PubMed ID: 29336531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carbon nanomaterials combined with metal nanoparticles for theranostic applications.
    Modugno G; Ménard-Moyon C; Prato M; Bianco A
    Br J Pharmacol; 2015 Feb; 172(4):975-91. PubMed ID: 25323135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
    Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
    Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Silicon nanomaterials platform for bioimaging, biosensing, and cancer therapy.
    Peng F; Su Y; Zhong Y; Fan C; Lee ST; He Y
    Acc Chem Res; 2014 Feb; 47(2):612-23. PubMed ID: 24397270
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activatable Theranostics.
    Huang P
    Curr Med Chem; 2019; 26(8):1310. PubMed ID: 31189459
    [No Abstract]   [Full Text] [Related]  

  • 48. Polyvalent Nanoobjects for Precision Diagnostics.
    Omstead DT; Sjoerdsma J; Bilgicer B
    Annu Rev Anal Chem (Palo Alto Calif); 2019 Jun; 12(1):69-88. PubMed ID: 30811215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Versatile carbon nanoplatforms for cancer treatment and diagnosis: strategies, applications and future perspectives.
    Tang L; Li J; Pan T; Yin Y; Mei Y; Xiao Q; Wang R; Yan Z; Wang W
    Theranostics; 2022; 12(5):2290-2321. PubMed ID: 35265211
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carbon Dots as Nanotherapeutics for Biomedical Application.
    Cohen EN; Kondiah PPD; Choonara YE; du Toit LC; Pillay V
    Curr Pharm Des; 2020; 26(19):2207-2221. PubMed ID: 32238132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Function-driven engineering of 1D carbon nanotubes and 0D carbon dots: mechanism, properties and applications.
    Xu Q; Li W; Ding L; Yang W; Xiao H; Ong WJ
    Nanoscale; 2019 Jan; 11(4):1475-1504. PubMed ID: 30620019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanomaterials for theranostics: recent advances and future challenges.
    Lim EK; Kim T; Paik S; Haam S; Huh YM; Lee K
    Chem Rev; 2015 Jan; 115(1):327-94. PubMed ID: 25423180
    [No Abstract]   [Full Text] [Related]  

  • 53. Red-Emissive Carbon Dots for Fluorescent, Photoacoustic, and Thermal Theranostics in Living Mice.
    Ge J; Jia Q; Liu W; Guo L; Liu Q; Lan M; Zhang H; Meng X; Wang P
    Adv Mater; 2015 Jul; 27(28):4169-77. PubMed ID: 26045099
    [No Abstract]   [Full Text] [Related]  

  • 54. Emerging two-dimensional monoelemental materials (Xenes) for biomedical applications.
    Tao W; Kong N; Ji X; Zhang Y; Sharma A; Ouyang J; Qi B; Wang J; Xie N; Kang C; Zhang H; Farokhzad OC; Kim JS
    Chem Soc Rev; 2019 Jun; 48(11):2891-2912. PubMed ID: 31120049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantum dots in nanomedicine: recent trends, advances and unresolved issues.
    Volkov Y
    Biochem Biophys Res Commun; 2015 Dec; 468(3):419-27. PubMed ID: 26168726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Facile Synthesis of Fluorescent Hyper-Cross-Linked β-Cyclodextrin-Carbon Quantum Dot Hybrid Nanosponges for Tumor Theranostic Application with Enhanced Antitumor Efficacy.
    Pei M; Pai JY; Du P; Liu P
    Mol Pharm; 2018 Sep; 15(9):4084-4091. PubMed ID: 30040427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional Carbon Quantum Dots for Ocular Imaging and Therapeutic Applications.
    Kumar VB; Sher I; Rencus-Lazar S; Rotenstreich Y; Gazit E
    Small; 2023 Feb; 19(7):e2205754. PubMed ID: 36461689
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy.
    Medina-Reyes EI; Garcia-Viacobo D; Carrero-Martinez FA; Chirino YI
    Crit Rev Ther Drug Carrier Syst; 2017; 34(1):35-61. PubMed ID: 28322140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.
    Zayed DG; AbdElhamid AS; Freag MS; Elzoghby AO
    Nanomedicine (Lond); 2019 Feb; 14(3):225-228. PubMed ID: 30652951
    [No Abstract]   [Full Text] [Related]  

  • 60. Carbon-based hybrid nanogels: a synergistic nanoplatform for combined biosensing, bioimaging, and responsive drug delivery.
    Wang H; Chen Q; Zhou S
    Chem Soc Rev; 2018 Jun; 47(11):4198-4232. PubMed ID: 29667656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.